| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 |
| V729181 | MACKLIN | 维生素D2标准溶液 | 1mg/mL in ethanol | 580元/1ml; | 展开 |
|
| V797007 | MACKLIN | 维生素D2 | 10mM in DMSO | 360元/1ml; | 展开 |
|
| E808864 | MACKLIN | 维生素D2 | 98% | 128元/200mg; 268元/1g; 916元/5g; 4145元/25g; | 展开 |
|
| C0005 | TCI | Calciferol | >98.0%(HPLC) | 525元/1G; | 展开 |
基本信息 | 纯度/分析方法 | >98.0%(HPLC) | | 分子式/分子量 | C28H44O = 396.66 | | 外观与形状(20℃) | 固体 | | 储存温度 | 0-10℃ | | 储存在惰性气体下 | 存放于惰性气体之中 | | 应避免的情况 | 光,空气,加热 | | 包装和容器 | 1G-带有塑料内管的玻璃瓶 (查看图片) | | PubChem物质ID | 87565217 | | SDBS (AIST Spectral DB) | 7750 | | Merck Index (14) | 10018 | | MDL编号 | MFCD00166988 |
技术规格 | Appearance | White powder to crystal | | Purity(HPLC) | min. 98.0 area% | | Melting point | 111.0 to 116.0 ℃ | | Specific rotation [a]20/D | +100 to +109 deg(C=1.5, EtOH) |
物性(参考值) | 熔点 | 114 ℃ | | 比旋光度 [α]D | 105° (C=1.5,EtOH) | | 水溶性 | 不溶 | | 溶解性(可溶于) | 醇,氯仿,乙醚 |
安全信息 | 图形或危害标志 |  | | 信号词 | 危险 | | 危险性说明 | H300 : 吞咽致命。
| | 防范说明 | P501 : 将内装物/容器送到批准的废物处理厂处理。 P270 : 使用本产品时不要进食、饮水或吸烟。 P264 : 作业后彻底清洗皮肤。 P301 + P310 + P330 : 如误吞咽:立即呼叫急救中心/医生。漱口。 P405 : 存放处须加锁。
|
相关法规 运输信息 | UN编号 | UN2811 | | 类别 | 6.1 | | 包装类别 | II | | 监管条件代码(*) | |
|
| 119230 | J&K | Vitamin D2 | 98%, 40000 国际单位/毫克 | 520元/1G; 1800元/5G; | 展开 |
基本信息 | 分子式 | C28H44O | | 分子量 | 396.65 | | 熔点 | 114 | | MDL编码 | MFCD00166988 | | Beilstein | 1916682 | | Merck | 14,10018 | | EINECS 编号 | 200-014-9 | | 存储条件 | Store at 2-8℃ | 一般描述 麦角钙化醇或骨化醇由麦角固醇受(紫外线)照射而产生。它是植物来源的维生素D。麦角钙化醇是维生素 D 的两种补充形式之一。它是一种脂溶性维生素。 应用 麦角钙化醇已被用作测量食品样品中维生素 D3 水平的标准。 生化/生理作用 麦角钙化醇(维生素D2)对人维生素缺乏相关疾病的治疗潜力低于胆钙化醇(维生素D3)。补充充足剂量的维生素D2可预防婴幼儿佝偻病,还能治疗成人软骨病。麦角钙化醇(维生素 D2)和 25-羟基胆钙化醇(维生素 D3)是维生素 D 的两种形式,其通过羟基化在体内活化。维生素 D2 和 D3 可广泛用于评估其对免疫和钙稳态等功能的影响的研究中。 安全信息 | 图形或危害标志 |   | | 提示语 | Danger | | 危险说明 | H301 H311 H330 H372 | | 防范说明 | P260 P280 P284 P301+P310 P310 | | UN号码 | 2811 | | 危险分类 | 6.1 | | 包装等级 | II | | WGK | 2 | | RTECS | KE1050000 | | TSCA | 是 |
|
| 95220 | Sigma-Aldrich | Ergocalciferol | ≥98.0% (sum of enantiomers, HPLC) | 1092.47元/1 G; 3171.71元/5 G; | 展开 |
产品说明 一般描述 麦角钙化醇或骨化醇由麦角固醇受(紫外线)照射而产生。它是植物来源的维生素D。 麦角钙化醇是维生素 D 的两种补充形式之一。它是一种脂溶性维生素。 应用 麦角钙化醇已被用作测量食品样品中维生素 D3 水平的标准。 生化/生理作用 麦角钙化醇(维生素D2)对人维生素缺乏相关疾病的治疗潜力低于胆钙化醇(维生素D3)。补充充足剂量的维生素D2可预防婴幼儿佝偻病,还能治疗成人软骨病。 麦角钙化醇(维生素 D2)和 25-羟基胆钙化醇(维生素 D3)是维生素 D 的两种形式,其通过羟基化在体内活化。维生素 D2 和 D3 可广泛用于评估其对免疫和钙稳态等功能的影响的研究中。 基本信息 | 经验(实验)分子式 | C28H44O | | 分子量 | 396.65 | | Beilstein | 1916682 | | EC 号 | 200-014-9 | | MDL编号 | MFCD00166988 | | eCl@ss | 34058017 | | PubChem化学物质编号 | 57653661 | | NACRES | NA.79 |
产品性质 | 质量水平 | 100 | | 生物来源 | synthetic | | 测定 | ≥98.0% (sum of enantiomers, HPLC) | | 旋光性 | [α]20/D +105±2°, c = 4% in ethanol | | 颜色 | colorless to white | | mp | 114-118 ℃ (lit.) 114-118 ℃ | | 储存温度 | 2-8℃ | | SMILES string | CC(C)[C@@H](C)/C=C/[C@@H](C)[C@@]1([H])CC[C@@]([C@]1(C)CCC/2)([H])C2=C\C=C(C[C@@H](O)CC3)/C3=C | | InChI | 1S/C28H44O/c1-19(2)20(3)9-10-22(5)26-15-16-27-23(8-7-17-28(26,27)6)12-13-24-18-25(29)14-11-21(24)4/h9-10,12-13,19-20,22,25-27,29H,4,7-8,11,14-18H2,1-3,5-6H3/b10-9+,23-12+,24-13-/t20-,22+,25-,26+,27-,28+/m0/s1 | | InChI key | MECHNRXZTMCUDQ-RKHKHRCZSA-N | | Gene Information | human ... VDR(7421) |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 + H311 - H330 - H372 | | 预防措施声明 | P260 - P264 - P280 - P302 + P352 + P312 - P304 + P340 + P310 - P314 | | 危险分类 | Acute Tox. 2 Inhalation - Acute Tox. 3 Dermal - Acute Tox. 3 Oral - STOT RE 1 Oral | | 储存分类代码 | 6.1A - Combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | Eyeshields, Faceshields, Gloves, type P1 (EN143) respirator filter, type P3 (EN 143) respirator cartridges |
|
| E5750 | Sigma-Aldrich | Ergocalciferol | 40,000,000 USP units/g | 958.9元/1 G; 2793.03元/5 G; 11136.4元/25 G; | 展开 |
产品说明 一般描述 维生素 D2 或麦角钙化醇可以通过膳食补充剂或植物来源获得。它是一种脂溶性维生素原。 应用 麦角钙化醇已被用作大鼠饮食的一个组成部分,以研究其生物利用度从紫外线照射的富 D2-酵母。它还被用作鉴别和定量维生素的标准,作为确定食用鱼营养成分研究的一部分。 包装 1, 5, 25 g in ampule 密封安瓿瓶。 生化/生理作用 麦角钙化醇(维生素 D2)和25-羟基胆钙化醇(维生素 D3)是维生素 D 的两种形式,它们可通过羟基化在体内 活化。维生素 D2 和 D3 可用于广泛的研究,以评估其对免疫功能和钙稳态等功能的影响。 麦角钙化醇用于抗佝偻病治疗。维生素 D 对骨矿化有积极作用。严重缺乏这种维生素会导致骨软化症和软骨病。 数量 1 USP 单位 = 1 I.U. 基本信息 | 经验(实验)分子式 | C28H44O | | 分子量 | 396.65 | | Beilstein | 1916682 | | EC 号 | 200-014-9 | | MDL编号 | MFCD00166988 | | eCl@ss | 34058017 | | PubChem化学物质编号 | 24894344 | | NACRES | NA.79 |
产品性质 | 质量水平 | 200 | | 生物来源 | synthetic (organic) | | 测定 | ≥97% | | 形式 | powder | | specific activity | 40,000,000 USP units/g | | technique(s) | HPLC: suitable | | 颜色 | white to off-white | | mp | 114-118 ℃ (lit.) | | 储存温度 | 2-8℃ | | SMILES string | CC(C)[C@@H](C)/C=C/[C@@H](C)[C@@]1([H])CC[C@@]([C@]1(C)CCC/2)([H])C2=C\C=C(C[C@@H](O)CC3)/C3=C | | InChI | 1S/C28H44O/c1-19(2)20(3)9-10-22(5)26-15-16-27-23(8-7-17-28(26,27)6)12-13-24-18-25(29)14-11-21(24)4/h9-10,12-13,19-20,22,25-27,29H,4,7-8,11,14-18H2,1-3,5-6H3/b10-9+,23-12+,24-13-/t20-,22+,25-,26+,27-,28+/m0/s1 | | InChI key | MECHNRXZTMCUDQ-RKHKHRCZSA-N | | Gene Information | human ... VDR(7421) |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 + H311 - H330 - H372 | | 预防措施声明 | P260 - P264 - P280 - P302 + P352 + P312 - P304 + P340 + P310 - P314 | | 危险分类 | Acute Tox. 2 Inhalation - Acute Tox. 3 Dermal - Acute Tox. 3 Oral - STOT RE 1 Oral | | 储存分类代码 | 6.1A - Combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | Eyeshields, Faceshields, Gloves, type P1 (EN143) respirator filter, type P3 (EN 143) respirator cartridges |
|
| E0900000 | | Ergocalciferol | European Pharmacopoeia (EP) Reference Standard | 1572.27元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. Ergocalciferol is a form of vitamin D, synthesized by some plants in the presence of UVB light. It can be obtained from diet intake or supplements. 应用 Ergocalciferol may be used as an analytical reference standard for the quantification of the analyte in foods using liquid chromatography coupled to selected reaction monitoring (SRM) mass spectrometry. 包装 Unit quantity: 70 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C28H44O | | 分子量 | 396.65 | | Beilstein | 1916682 | | MDL编号 | MFCD00166988 | | PubChem化学物质编号 | 329798871 | | NACRES | NA.24 |
产品性质 | 生物来源 | synthetic | | 等级 | pharmaceutical primary standard | | agency | EP | | 形式 | solid | | manufacturer/tradename | EDQM | | technique(s) | gas chromatography (GC): suitable liquid chromatography (LC): suitable | | mp | 114-118 ℃ (lit.) | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | −20℃ | | SMILES string | CC(C)[C@@H](C)/C=C/[C@@H](C)[C@@]1([H])CC[C@@]([C@]1(C)CCC/2)([H])C2=C\C=C(C[C@@H](O)CC3)/C3=C | | InChI | 1S/C28H44O/c1-19(2)20(3)9-10-22(5)26-15-16-27-23(8-7-17-28(26,27)6)12-13-24-18-25(29)14-11-21(24)4/h9-10,12-13,19-20,22,25-27,29H,4,7-8,11,14-18H2,1-3,5-6H3/b10-9+,23-12+,24-13-/t20-,22+,25-,26+,27-,28+/m0/s1 | | InChI key | MECHNRXZTMCUDQ-RKHKHRCZSA-N | | Gene Information | human ... VDR(7421) |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 + H311 - H330 - H372 | | 预防措施声明 | P260 - P264 - P280 - P302 + P352 + P312 - P304 + P340 + P310 - P314 | | 危险分类 | Acute Tox. 2 Inhalation - Acute Tox. 3 Dermal - Acute Tox. 3 Oral - STOT RE 1 Oral | | 储存分类代码 | 6.1A - Combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1239005 | USP | Ergocalciferol | United States Pharmacopeia (USP) Reference Standard | 3572.92元/5 X 30 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C28H44O | | 分子量 | 396.65 | | Beilstein | 1916682 | | MDL编号 | MFCD00166988 | | PubChem化学物质编号 | 329749739 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | mp | 114-118 ℃ (lit.) | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | −20℃ | | SMILES string | CC(C)[C@@H](C)/C=C/[C@@H](C)[C@@]1([H])CC[C@@]([C@]1(C)CCC/2)([H])C2=C\C=C(C[C@@H](O)CC3)/C3=C | | InChI | 1S/C28H44O/c1-19(2)20(3)9-10-22(5)26-15-16-27-23(8-7-17-28(26,27)6)12-13-24-18-25(29)14-11-21(24)4/h9-10,12-13,19-20,22,25-27,29H,4,7-8,11,14-18H2,1-3,5-6H3/b10-9+,23-12+,24-13-/t20-,22+,25-,26+,27-,28+/m0/s1 | | InChI key | MECHNRXZTMCUDQ-RKHKHRCZSA-N | | Gene Information | human ... VDR(7421) |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 + H311 - H330 - H372 | | 预防措施声明 | P260 - P264 - P280 - P302 + P352 + P312 - P304 + P340 + P310 - P314 | | 危险分类 | Acute Tox. 2 Inhalation - Acute Tox. 3 Dermal - Acute Tox. 3 Oral - STOT RE 1 Oral | | 储存分类代码 | 6.1A - Combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| PHR1238 | Supelco | Ergocalciferol (Vitamin D2) | Pharmaceutical Secondary Standard; Certified Reference Material | 1904.93元/500 MG; | 展开 |
产品说明 一般描述 用于质量控制的制药二级标准品,为制药实验室和制造商制备内部工作标准品提供了一种方便、高性价比的替代方案。 应用 钙化醇(维生素D2)作为药物参考标准品,用于通过各种色谱技术测定血清样本、化妆品和制药配方中的分析物。 这些二级标准品是经过检验的认证标准物质(CRM)。它们适用于多种分析应用,包括但不限于药物释放测试、药物的定性和定量分析方法开发、食品和饮料质量控制检测以及其他标定应用。 分析说明 这些二级标准品可追溯至USP、EP(PhEur)和BP一级标准品。 其他说明 该认证标准物质(CRM)根据ISO 17034 和 ISO/IEC 17025进行生产和认证。有关此CRM使用的所有信息均可在分析证书上找到。 附注 要查看该物质的分析证书示例,请在下面的位置输入LRAB7854。这只是一个示例证书,可能与您收到的批次不符。 基本信息 | 经验(实验)分子式 | C28H44O | | 分子量 | 396.65 | | Beilstein | 1916682 | | EC 号 | 200-014-9 | | MDL编号 | MFCD00166988 | | PubChem化学物质编号 | 329823243 |
产品性质 | 质量水平 | 300 | | 等级 | certified reference material pharmaceutical secondary standard | | CofA | current certificate can be downloaded | | technique(s) | HPLC: suitable gas chromatography (GC): suitable | | mp | 114-118 ℃ (lit.) | | application(s) | clinical testing | | 格式 | neat | | 药典可追溯性 | traceable to BP 788 traceable to PhEur E0900000 traceable to USP 1239005 | | 储存温度 | -10 to -25℃ | | SMILES string | CC(C)[C@@H](C)/C=C/[C@@H](C)[C@@]1([H])CC[C@@]([C@]1(C)CCC/2)([H])C2=C\C=C(C[C@@H](O)CC3)/C3=C | | InChI | 1S/C28H44O/c1-19(2)20(3)9-10-22(5)26-15-16-27-23(8-7-17-28(26,27)6)12-13-24-18-25(29)14-11-21(24)4/h9-10,12-13,19-20,22,25-27,29H,4,7-8,11,14-18H2,1-3,5-6H3/b10-9+,23-12+,24-13-/t20-,22+,25-,26+,27-,28+/m0/s1 | | InChI key | MECHNRXZTMCUDQ-RKHKHRCZSA-N | | Gene Information | human ... VDR(7421) |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 + H311 - H330 - H372 | | 预防措施声明 | P260 - P264 - P280 - P302 + P352 + P312 - P304 + P340 + P310 - P314 | | 危险分类 | Acute Tox. 2 Inhalation - Acute Tox. 3 Dermal - Acute Tox. 3 Oral - STOT RE 1 Oral | | 储存分类代码 | 6.1A - Combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| Y0001375 | | Ergocalciferol for system suitability | European Pharmacopoeia (EP) Reference Standard | 1572.27元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. Ergocalciferol is a fat soluble vitamin and one of the two forms of supplemental vitamin D available, which is activated in vivo by hydroxylation. 包装 Unit quantity: 10 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C28H44O | | 分子量 | 396.65 | | Beilstein | 1916682 | | MDL编号 | MFCD00166988 | | PubChem化学物质编号 | 329831389 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | 颜色 | white | | mp | 114-118 ℃ (lit.) | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | −20℃ | | SMILES string | CC(C)[C@@H](C)/C=C/[C@@H](C)[C@@]1([H])CC[C@@]([C@]1(C)CCC/2)([H])C2=C\C=C(C[C@@H](O)CC3)/C3=C | | InChI | 1S/C28H44O/c1-19(2)20(3)9-10-22(5)26-15-16-27-23(8-7-17-28(26,27)6)12-13-24-18-25(29)14-11-21(24)4/h9-10,12-13,19-20,22,25-27,29H,4,7-8,11,14-18H2,1-3,5-6H3/b10-9+,23-12+,24-13-/t20-,22+,25-,26+,27-,28+/m0/s1 | | InChI key | MECHNRXZTMCUDQ-RKHKHRCZSA-N | | Gene Information | human ... VDR(7421) |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 + H311 - H330 - H372 | | 预防措施声明 | P260 - P264 - P280 - P302 + P352 + P312 - P304 + P340 + P310 - P314 | | 危险分类 | Acute Tox. 2 Inhalation - Acute Tox. 3 Dermal - Acute Tox. 3 Oral - STOT RE 1 Oral | | 储存分类代码 | 6.1A - Combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| BP788 | | Ergocalciferol | British Pharmacopoeia (BP) Reference Standard | 2189.77元/500 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. Ergocalciferol is a fat soluble vitamin and one of the two forms of supplemental vitamin D available, which is activated in vivo by hydroxylation. 包装 Unit quantity: 500 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C28H44O | | 分子量 | 396.65 | | Beilstein | 1916682 | | EC 号 | 200-014-9 | | MDL编号 | MFCD00166988 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | BP | | 颜色 | white | | mp | 114-118 ℃ (lit.) | | 格式 | neat | | 储存温度 | −20℃ | | SMILES string | CC(C)[C@@H](C)/C=C/[C@@H](C)[C@@]1([H])CC[C@@]([C@]1(C)CCC/2)([H])C2=C\C=C(C[C@@H](O)CC3)/C3=C | | InChI | 1S/C28H44O/c1-19(2)20(3)9-10-22(5)26-15-16-27-23(8-7-17-28(26,27)6)12-13-24-18-25(29)14-11-21(24)4/h9-10,12-13,19-20,22,25-27,29H,4,7-8,11,14-18H2,1-3,5-6H3/b10-9+,23-12+,24-13-/t20-,22+,25-,26+,27-,28+/m0/s1 | | InChI key | MECHNRXZTMCUDQ-RKHKHRCZSA-N | | Gene Information | human ... VDR(7421) |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 + H311 - H330 - H372 | | 预防措施声明 | P260 - P264 - P280 - P302 + P352 + P312 - P304 + P340 + P310 - P314 | | 危险分类 | Acute Tox. 2 Inhalation - Acute Tox. 3 Dermal - Acute Tox. 3 Oral - STOT RE 1 Oral | | 储存分类代码 | 6.1A - Combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| VIT-022N | AccuStandard | Vitamin D2 | | 428元/100mg; | 展开 |
| Ergocalciferol | 维生素D2 | 50-14-6 | |
|